Navigation Links
Terminally Ill Patients Could Be Offered A Better Life

Terminally ill people have the right to a life of dignity with access to medicines and care that help ease the pain which often accompanies diseases like cancer, say experts on the eve of World Hospice and Palliative Care Day. // Currently, only a few states like Kerala, Maharashtra, Karnataka and Orissa as well as the Delhi administration have provisions that allows care-giving organizations to administer strong painkillers that make life more bearable.

But the experts say all state government should frame laws that allow organizations to play a more dynamic role in easing the pain of the terminally ill.

Drawing attention to the needs of the terminally ill and also those who stand a better chance of cure if given treatment in time, Indian groups will join global bodies to mark Oct 8 as World Hospice and Palliative Care Day.

"State governments need to replace ancient rules that cause some impediments in providing terminally ill people with analgesics and opiates that can make life easier in the last stages," said Dinesh Goswami, secretary of the Indian Association of Palliative Care and of Guwahati Pain and Palliative Care Society.

"There is still not enough awareness among people and physicians about the need to make medicines available to help ease the pain which often makes life an agony not only for patients and caregivers," Goswami told IANS.

Kerala has a demonstration hospices centre attached to the Calicut Medical College that was set up by the World Health Organization and is run by the local member of the Indian Association of Palliative Care. The facility not only provides training but is also a regional research and development centre.

People from neighbouring countries like Bangladesh and Sri Lanka come there for training.

Earlier this year, Delhi-based CanSupport, an NGO providing palliative care to people with advanced cancer, was given the morphine licence after five years
'"/>




Page: 1 2

Related medicine news :

1. Terminally Ill deserves a better quality of Life
2. Terminally Ill Children Require Home Care
3. Terminally Ill Cancer Patients Are Not Getting Cash Benefits
4. Terminally Ill: End Of Life Choices
5. Report Calls For Better Implementation Of Last Wishes of Terminally Ill
6. Terminally Ill Patients Asked To Depute People To Make Decisions
7. One in Three Heart Attack Patients Have No Chest Pains
8. Amphetamines Help Recovery of Stroke Patients
9. Painkillers Do Not Shorten Dying Patients Lives
10. Patients With Filariasis More Prone To HIV Infection
11. Glivec - New Hope For CMC Patients
Post Your Comments:
Breaking Medicine Technology:The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8Steaz Launches Organic Zero Calorie Sparkling Line 59893 1Steaz Launches Organic Zero Calorie Sparkling Line 59893 2Henry Schein to Webcast Third Quarter 2009 Conference Call Wednesday November 4 at 10 A M EST 59891 1Henry Schein to Webcast Third Quarter 2009 Conference Call Wednesday November 4 at 10 A M EST 59891 2Bioidentical Hormones a True Prevention for Breast Cancer 59889 1Bioidentical Hormones a True Prevention for Breast Cancer 59889 2